JAMA Internal Medicine - McMaster Experts

publication venue for

Association of Particulate Matter Exposure With Lung Function and Mortality Among Patients With Fibrotic Interstitial Lung Disease. 182:1248-1248. 2022
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines. 182:376-376. 2022
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19. 181:1612-1612. 2021
Fishing for an Association With Sudden Cardiac Death—Reply. 181:1140-1140. 2021
Assessment of Psychotropic Drug Prescribing Among Nursing Home Residents in Ontario, Canada, During the COVID-19 Pandemic. 181:861-861. 2021
Associations of Fish Consumption With Risk of Cardiovascular Disease and Mortality Among Individuals With or Without Vascular Disease From 58 Countries. 181:631-631. 2021
Media Portrayals of Outcomes After Extracorporeal Membrane Oxygenation. 181:391-391. 2021
Association Between Nursing Home Crowding and COVID-19 Infection and Mortality in Ontario, Canada. 181:229-229. 2021
Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. 180:1447-1447. 2020
Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply. 180:333-333. 2020
Safety of the Use of Radioactive Iodine in Patients With Hyperthyroidism. 179:1738-1738. 2019
Perioperative Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant. 179:1469-1469. 2019
Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. 179:1025-1025. 2019
Association Between the Publication of the Initiating Dialysis Early and Late Trial and the Timing of Dialysis Initiation in Canada. 179:934-934. 2019
Methodological Issues in Determining the Accuracy of Automated Office Blood Pressure Readings for Diagnosing Hypertension—Reply. 179:850-850. 2019
Comparing Automated Office Blood Pressure Readings With Other Methods of Blood Pressure Measurement for Identifying Patients With Possible Hypertension. 179:351-351. 2019
Evaluating Progression-Free Survival as a Surrogate Outcome for Health-Related Quality of Life in Oncology. 178:1586-1586. 2018
A Randomized Clinical Trial of n-of-1 Trials—Tribulations of a Trial. 178:1378-1378. 2018
Association of Overlapping Surgery With Increased Risk for Complications Following Hip Surgery. 178:75-75. 2018
Fecal Immunochemical Tests in Patients at Increased Risk for Colorectal Cancer—Is It Prime Time Yet?. 177:1119-1119. 2017
Guidance for Modifying the Definition of Diseases. 177:1020-1020. 2017
Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes. 177:61-61. 2017
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis. 176:1464-1464. 2016
The Burden of Hypertension and Associated Risk for Cardiovascular Mortality in China. 176:524-524. 2016
Mobile Text Messaging and Adherence of Patients to Medication Prescriptions. 176:350-350. 2016
Comparison of Radiation Doses and Best-Practice Use for Myocardial Perfusion Imaging in US and Non-US Laboratories. 176:266-266. 2016
Estimating the Reduction in the Radiation Burden From Nuclear Cardiology Through Use of Stress-Only Imaging in the United States and Worldwide. 176:269-269. 2016
Medical Directive for Urinary Catheter Removal by Nurses on General Medical Wards. 176:113-113. 2016
Nutritional Support and Outcomes in Malnourished Medical Inpatients. 176:43-43. 2016
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis. 175:1474-1474. 2015
Working to Shift Clinician Perceptions—Reply. 175:1578-1578. 2015
Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. 175:1163-1163. 2015
Barriers to Goals of Care Discussions With Seriously Ill Hospitalized Patients and Their Families. 175:549-549. 2015
Falls and Fractures With Atypical Antipsychotic Medication Use. 175:450-450. 2015
Infection Management and Multidrug-Resistant Organisms in Nursing Home Residents With Advanced Dementia. 174:1660-1660. 2014
A Comparison of Live Counseling With a Web-Based Lifestyle and Medication Intervention to Reduce Coronary Heart Disease Risk. 174:1144-1144. 2014
Cognitive Function and Brain Structure in Persons With Type 2 Diabetes Mellitus After Intensive Lowering of Blood Pressure and Lipid Levels. 174:324-324. 2014
Warfarin Interactions With Antibiotics in the Ambulatory Care Setting. 174:409-409. 2014
Statins and Musculoskeletal Adverse Events. 174:302-302. 2014
Statins and Musculoskeletal Adverse Events. 174:302-302. 2014
Cardiac Symptoms in Women and Men—Reply. 173:1929-1929. 2013
Diet and Kidney Disease in High-Risk Individuals With Type 2 Diabetes Mellitus. 173:1682-1692. 2013
Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease. 173:1175-1175. 2013
Failure to Engage Hospitalized Elderly Patients and Their Families in Advance Care Planning. 173:778-778. 2013
Reconstructing Angina: Cardiac Symptoms Are the Same in Women and Men. 173:829-829. 2013
Resumption of Warfarin Therapy After Gastrointestinal Tract Bleeding: Benefit or Bias?—Reply. 173:833-833. 2013
High Variation Between Hospitals in Vena Cava Filter Use for Venous Thromboembolism. 173:506-506. 2013
Indications, Complications, and Management of Inferior Vena Cava Filters. 173:513-513. 2013
High-Five for High-Sensitivity Cardiac Troponin T: Depends on the Precision and Analytical Platform. 173:477-477. 2013
Effect of Legumes as Part of a Low Glycemic Index Diet on Glycemic Control and Cardiovascular Risk Factors in Type 2 Diabetes Mellitus. 172:1653-1653. 2012
Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation. 172:1687-1687. 2012
The PLAN Score. 172:1548-1548. 2012
Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding. 172:1484-1484. 2012
Long-Acting β₂-Agonist Step-off in Patients With Controlled Asthma. 172:1365-1365. 2012
Nature and Impact of Grief Over Patient Loss on Oncologists' Personal and Professional Lives. 172:964-966. 2012
Fecal Transplant for Clostridium difficile —Reply. 172:825-826. 2012
The Increasing Burden of Atrial Fibrillation Compared With Heart Failure and Myocardial Infarction: A 15-Year Study of All Hospitalizations in Australia. 172:739-739. 2012
Use of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers and Cardiovascular Outcomes in Chronic Dialysis Patients: A Population-Based Cohort Study. 172:591-593. 2012
Do Procalcitonin Algorithms Modify Mortality?—Reply. 172:197-197. 2012
Fecal Transplant via Retention Enema for Refractory or Recurrent <emph type="ital">Clostridium difficile</emph> Infection. 172:191-191. 2012
Helicobacter pylori Eradication for Functional Dyspepsia: What Are We Treating?. 171:1936-1936. 2011
Shared Electronic Vascular Risk Decision Support in Primary Care. 171:1736-1736. 2011
Opioids and Dose-Related Deaths—Association or Causation?. 171:1687-1687. 2011
Opioids and Dose-Related Deaths—Association or Causation?—Reply. 171:1687-1687. 2011
Containing Antibiotic Resistance While Treating Community-Acquired Pneumonia. 171:1510-1510. 2011
Using the Appropriate Fishing Net for Computed Tomographic Coronary Angiography in Daily Clinical Practice. 171:1512-1512. 2011
Procalcitonin Algorithms for Antibiotic Therapy Decisions. 171:1322-1322. 2011
What Is a Reasonable Threshold for Worries About Health Risks?—Reply. 171:1401-1401. 2011
Ontario Multidetector Computed Tomographic Coronary Angiography Study. 171:1021-1029. 2011
The Optimal Timing of Smoking Cessation Before Surgery. 171:989-990. 2011
Reducing Polypharmacy: Is Hospitalization the Right Time?—Reply. 171:869-869. 2011
Opioid Dose and Drug-Related Mortality in Patients With Nonmalignant Pain. 171:686-691. 2011
Orlistat and Acute Kidney Injury: An Analysis of 953 Patients. 171:702-702. 2011
Effect of Cardiac Rehabilitation Referral Strategies on Utilization Rates. 171:235-235. 2011
Albuminuria and Decline in Cognitive Function<subtitle>The ONTARGET/TRANSCEND Studies</subtitle><alt-title>Albuminuria and Decline in Cognitive Function</alt-title>. 171:142-142. 2011
Risk of Recurrence After a First Episode of Symptomatic Venous Thromboembolism Provoked by a Transient Risk Factor. 170:1710-1716. 2010
Editor's Correspondence. 170:1695-1695. 2010
Effects of Lowering Homocysteine Levels With B Vitamins on Cardiovascular Disease, Cancer, and Cause-Specific Mortality<subtitle>Meta-analysis of 8 Randomized Trials Involving 37 485 Individuals</subtitle><alt-title>Effects of Lowering Homocysteine Levels</alt-title>. 170:1622-1622. 2010
Feasibility Study of a Systematic Approach for Discontinuation of Multiple Medications in Older Adults. 170:1648-1654. 2010
A Population-Based Study of Inferior Vena Cava Filters in Patients With Acute Venous Thromboembolism. 170:1456-1462. 2010
Influenza Vaccination and Vitamin K Antagonist Treatment. 170:609-616. 2010
The Diabetes Mellitus Medication Choice Decision Aid. 169:1560-1568. 2009
Low-Molecular-Weight Heparin as an Adjunct to Thrombolysis in ST Elevation Myocardial Infarction. 169:1163-1163. 2009
A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease. 169:659-659. 2009
Yield of Diagnostic Tests for Celiac Disease in Individuals With Symptoms Suggestive of Irritable Bowel Syndrome. 169:651-651. 2009
Twenty-Year Trends in the Incidence of Stroke Complicating Acute Myocardial Infarction. 168:2104-2104. 2008
Procalcitonin-Guided Antibiotic Use vs a Standard Approach for Acute Respiratory Tract Infections in Primary Care. 168:2000-2000. 2008
Prophylaxis Against Deep Vein Thrombosis in Critically Ill Patients With Severe Renal Insufficiency With the Low-Molecular-Weight Heparin Dalteparin<subtitle>An Assessment of Safety and Pharmacodynamics: The DIRECT Study</subtitle>. 168:1805-1805. 2008
The Hemoglobin A1c Level as a Progressive Risk Factor for Cardiovascular Death, Hospitalization for Heart Failure, or Death in Patients With Chronic Heart Failure. 168:1699-1699. 2008
Patient Outcomes After Deep Vein Thrombosis and Pulmonary Embolism<subtitle>The Worcester Venous Thromboembolism Study</subtitle>. 168:425-425. 2008
Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis. 168:1261-1269. 2008
A Possible Role of Recurrent Major Depression in Risk of Fracture—Reply. 167:2370-2370. 2007
Randomized Clinical Trial of Homocysteine Level–Lowering Therapy and Fractures. 167:2136-2136. 2007
Increasing Use of Single and Combination Medical Therapy in Patients Hospitalized for Acute Myocardial Infarction in the 21st Century<subtitle>A Multinational Perspective</subtitle>. 167:1766-1766. 2007
Venous Thromboembolism in the Outpatient Setting. 167:1471-1471. 2007
One-Year Outcomes and Health Care Utilization in Survivors of Severe Acute Respiratory Syndrome. 167:1312-1312. 2007
Passive Transfer of Peanut Hypersensitivity by Fresh Frozen Plasma. 167:853-853. 2007
Acute vs Chronic Secondhand Smoke Exposure—Reply. 167:731-731. 2007
Interventions to Enhance Medication Adherence in Chronic Medical Conditions. 167:540-540. 2007
Long-term Survival After Heart Failure. 167:490-490. 2007
Simple Clinical Predictors May Obviate Urgent Endoscopy in Selected Patients With Nonvariceal Upper Gastrointestinal Tract Bleeding. 167:265-265. 2007
Combined Aspirin–Oral Anticoagulant Therapy Compared With Oral Anticoagulant Therapy Alone Among Patients at Risk for Cardiovascular Disease. 167:117-117. 2007
Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture. 167:188-188. 2007
Elevated Cardiac Troponin Measurements in Critically Ill Patients. 166:2446-2446. 2006
Guillain-Barré Syndrome After Influenza Vaccination in Adults. 166:2217-2217. 2006
Lifetime Cumulative Exposure to Secondhand Smoke and Risk of Myocardial Infarction in Never Smokers. 166:1961-1961. 2006
Definition of Low-Fat Diets—Reply. 166:1420-1420. 2006
Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin. 166:853-853. 2006
Risk of Recurrent Venous Thromboembolism in Patients With Common Thrombophilia. 166:729-729. 2006
Effects of Low-Carbohydrate vs Low-Fat Diets on Weight Loss and Cardiovascular Risk Factors. 166:285-285. 2006
Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole. 165:2540-2540. 2005
Comments on the Important Drug Interaction of Warfarin and Sulfamethoxazole—Reply. 165:2540-2540. 2005
The Tension Between E-Health Innovation and E-Valuation. 165:2329-2329. 2005
The (Variable) Definition of Benefit in the Case of Clopidogrel vs Aspirin—Reply. 165:1310-1310. 2005
Systematic Overview of Warfarin and Its Drug and Food Interactions. 165:1095-1095. 2005
A Prescribing Cascade Involving Cholinesterase Inhibitors and Anticholinergic Drugs. 165:808-808. 2005
Effect of Different Antilipidemic Agents and Diets on Mortality. 165:725-725. 2005
Efficacy and Safety of Fixed Low-Dose Dalteparin in Preventing Venous Thromboembolism Among Obese or Elderly Hospitalized Patients. 165:341-341. 2005
A Systematic Review and Meta-analysis of Studies Comparing Readmission Rates and Mortality Rates in Patients With Heart Failure. 164:2315-2315. 2004
Comparative Benefits of Clopidogrel and Aspirin in High-Risk Patient Populations. 164:2106-2106. 2004
Early Withdrawal of Statin Therapy in Patients With Non–ST-Segment Elevation Myocardial Infarction<subtitle>National Registry of Myocardial Infarction</subtitle>. 164:2162-2162. 2004
Change in Thrombus Length on Venous Ultrasound and Recurrent Deep Vein Thrombosis. 164:1793-1793. 2004
Implications of Diabetes in Patients With Acute Coronary Syndromes<subtitle>The Global Registry of Acute Coronary Events</subtitle>. 164:1457-1457. 2004
Low-Molecular-Weight Heparin as Bridging Anticoagulation During Interruption of Warfarin. 164:1319-1319. 2004
Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical Illness. 164:963-963. 2004
A Comparison of the Effects of Raloxifene and Conjugated Equine Estrogen on Bone and Lipids in Healthy Postmenopausal Women. 164:871-871. 2004
Declining Length of Hospital Stay for Acute Myocardial Infarction and Postdischarge Outcomes. 164:733-733. 2004
Establishing an Optimal Therapeutic Range for Coumarins. 164:588-588. 2004
Treatment of Heparin-Induced Thrombocytopenia. 164:361-361. 2004
Clinical relevance of bleeding index - In reply. 163:2794-2795. 2003
An Improved Definition of Immune Heparin-Induced Thrombocytopenia in Postoperative Orthopedic Patients. 163:2518-2518. 2003
Cost-effectiveness of Newer Antiplatelet Drugs—Reply. 163:2533-2533. 2003
Perioperative Management of Patients Receiving Oral Anticoagulants. 163:2532-2532. 2003
Communitywide Trends in the Use and Outcomes Associated With β-Blockers in Patients With Acute Myocardial Infarction. 163:2175-2175. 2003
Argatroban Anticoagulation in Patients With Heparin-Induced Thrombocytopenia. 163:1849-1849. 2003
Reduction of Out-of-Hospital Symptomatic Venous Thromboembolism by Extended Thromboprophylaxis With Low-Molecular-Weight Heparin Following Elective Hip Arthroplasty. 163:1362-1362. 2003
Low-molecular-weight heparin for anticougulation during continuous venovenous hemofiltration - Reply. 163:981-981. 2003
Perioperative Management of Patients Receiving Oral Anticoagulants. 163:901-901. 2003
Effectiveness of Amiodarone for Conversion of Atrial Fibrillation to Sinus Rhythm. 163:777-777. 2003
Clinical and Epidemiologic Features of Group A Streptococcal Pneumonia in Ontario, Canada. 163:467-467. 2003
Imaging Characteristics of a Novel Technetium Tc 99m–Labeled Platelet Glycoprotein IIb/IIIa Receptor Antagonist in Patients With Acute Deep Vein Thrombosis or a History of Deep Vein Thrombosis. 163:452-452. 2003
Is Impaired Renal Function a Contraindication to the Use of Low-Molecular-Weight Heparin?. 162:2605-2605. 2002
Fondaparinux vs Enoxaparin for the Prevention of Venous Thromboembolism in Major Orthopedic Surgery<subtitle>A Meta-analysis of 4 Randomized Double-blind Studies</subtitle>. 162:1833-1833. 2002
Overweight and Obesity as Determinants of Cardiovascular Risk. 162:1867-1867. 2002
Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement. 162:1465-1465. 2002
A Randomized Trial of the Effect of Community Pharmacist Intervention on Cholesterol Risk Management<subtitle>The Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)</subtitle>. 162:1149-1149. 2002
Early Effects of Raloxifene on Clinical Vertebral Fractures at 12 Months in Postmenopausal Women With Osteoporosis. 162:1140-1140. 2002
A Community-Wide Survey of Physician Practices and Attitudes Toward Cholesterol Management in Patients With Recent Acute Myocardial Infarction. 162:797-797. 2002
Elevated Cardiac Troponin Levels in Patients With Submassive Pulmonary Embolism. 162:79-79. 2002
Acute Precipitants of Congestive Heart Failure Exacerbations. 161:2337-2337. 2001
Prevention and Treatment of Postphlebitic Syndrome. 161:2105-2105. 2001
Low-Molecular-Weight Heparins in the Treatment of Acute Coronary Syndromes. 161:1484-1484. 2001
Temporal Trends (1986-1997) in Cholesterol Level Assessment and Management Practices in Patients With Acute Myocardial Infarction. 161:1521-1521. 2001
Deep Vein Thrombosis and Its Prevention in Critically Ill Adults. 161:1268-1268. 2001
Early Clinical Outcomes and Routine Management of Patients With Non–ST-Segment Elevation Myocardial Infarction. 161:601-601. 2001
A Latex D-Dimer Reliably Excludes Venous Thromboembolism. 161:447-447. 2001
Use of a Fixed Activated Partial Thromboplastin Time Ratio to Establish a Therapeutic Range for Unfractionated Heparin. 161:385-385. 2001
Clinical Risk Factors and Timing of Recurrent Venous Thromboembolism During the Initial 3 Months of Anticoagulant Therapy. 160:3431-3431. 2000
Low-Molecular-Weight and Unfractionated Heparin for Prevention of Venous Thromboembolism in Neurosurgery. 160:2327-2327. 2000
Warfarin Therapy for Atrial Fibrillation: The Patient's Preference Is Important. 160:2403-2403. 2000
A Randomized Trial of Improved Weight Loss With a Prepared Meal Plan in Overweight and Obese Patients. 160:2150-2150. 2000
Low-Molecular-Weight Heparin Prophylaxis Using Dalteparin in Close Proximity to Surgery vs Warfarin in Hip Arthroplasty Patients. 160:2199-2199. 2000
Effect of Smoking Cessation on Mortality After Myocardial Infarction. 160:939-939. 2000
Beyond Heparin and Aspirin. 160:749-749. 2000
Occurrence, Causes, and Outcome of Delirium in Patients With Advanced Cancer. 160:786-786. 2000
Postthrombotic Syndrome After Hip or Knee Arthroplasty. 160:669-672. 2000
Oral Anticoagulation Treatment in the Elderly. 160:470-470. 2000
A Meta-analysis Comparing Low-Molecular-Weight Heparins With Unfractionated Heparin in the Treatment of Venous Thromboembolism. 160:181-181. 2000
Anticoagulation of Pregnant Women With Mechanical Heart Valves. 160:191-191. 2000
Why Do Patients With Atrial Fibrillation Not Receive Warfarin?. 160:41-41. 2000
Assessing Cardiac Risk Assessment. 159:2226-2227. 1999
Economic Evaluation of Outpatient Treatment With Low-Molecular-Weight Heparin for Proximal Vein Thrombosis. 159:2298-2304. 1999
Recurrent Venous Thrombosis and Heparin Therapy. 159:2029-2029. 1999
Risk Factors for Pneumonia and Other Lower Respiratory Tract Infections in Elderly Residents of Long-term Care Facilities. 159:2058-2058. 1999
Non–Gastrointestinal Tract Associations of Helicobacter pylori Infection. 159:925-925. 1999
Diagnosis of Thyroid Disease in Hospitalized Patients. 159:658-658. 1999
Importance of pH Control in the Management of GERD. 159:649-649. 1999
Physician Estimates of Perioperative Cardiac Risk in Patients Undergoing Noncardiac Surgery. 159:713-713. 1999
A Randomized Trial Comparing 5-mg and 10-mg Warfarin Loading Doses. 159:46-46. 1999
Treating Helicobacter pylori. 158:2396-2398. 1998
Assessment of Outpatient Treatment of Deep-Vein Thrombosis With Low-Molecular-Weight Heparin. 158:2001-2001. 1998
Echocardiographic Predictors of Stroke in Patients With Atrial Fibrillation. 158:1316-1316. 1998
Effect of Warfarin on Activated Partial Thromboplastin Time in Patients Receiving Heparin. 158:1140-1140. 1998
Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?. 157:2550-2556. 1997
Duration of anticoagulant therapy after first episode of venous thrombosis in patients with inherited thrombophilia. 157:2174-2177. 1997
Bronchodilator delivery in acute airflow obstruction. A meta-analysis. 157:1736-1744. 1997
A reevaluation of the risk for venous thromboembolism with the use of oral contraceptives and hormone replacement therapy. 157:1522-1530. 1997
The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. 157:1413-1418. 1997
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. 157:1077-1081. 1997
A comparison of compression ultrasound with color Doppler ultrasound for the diagnosis of symptomless postoperative deep vein thrombosis. 157:765-768. 1997
Management of iliofemoral thrombosis in a pregnant patient with heparin resistance. 157:815-816. 1997
Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective. 157:298-303. 1997
Treatment of proximal vein thrombosis with subcutaneous low-molecular-weight heparin vs intravenous heparin. An economic perspective. 157:289-294. 1997
Nutritional management of cardiovascular risk factors. A randomized clinical trial. 157:169-177. 1997
How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. 156:2221-2224. 1996
A review and economic evaluation of bronchodilator delivery methods in hospitalized patients. 156:2113-2118. 1996
Multidisciplinary education for oxygen prescription. A continuous quality improvement study. 156:1797-1801. 1996
Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Clinical Quality Improvement Network Investigators. 156:1669-1673. 1996
The relation between the activated partial thromboplastin time response and recurrence in patients with venous thrombosis treated with continuous intravenous heparin. 156:1677-1681. 1996
Gender and ethnic differences in hospital-based procedure utilization in California. 156:1217-1224. 1996
Ardeparin (low-molecular-weight heparin) vs graduated compression stockings for the prevention of venous thromboembolism. A randomized trial in patients undergoing knee surgery. 156:851-856. 1996
The importance of quality of primary studies in producing unbiased systematic reviews. 156:661-666. 1996
Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. 155:1958-1964. 1995
Impedance Plethysmography for Suspected Deep-Vein Thrombosis-Reply. 155:776-776. 1995
Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis. 155:601-607. 1995
Starting prophylaxis for venous thromboembolism postoperatively. 155:366-372. 1995
Diagnostic tests for deep vein thrombosis. Clinical usefulness depends on probability of disease. 154:1921-1928. 1994
Reevaluation of the sensitivity of impedance plethysmography for the detection of proximal deep vein thrombosis. 154:1930-1933. 1994
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. 154:1449-1457. 1994
Idiopathic deep venous thrombosis. Is a search for malignant disease justified?. 154:1310-1312. 1994
Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. 154:982-987. 1994
A Noninvasive Strategy for the Treatment of Patients With Suspected Pulmonary Embolism. 154:289-289. 1994
The international normalized ratio. A guide to understanding and correcting its problems. 154:282-288. 1994
A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. 154:49-56. 1994
Graduated compression stockings in the prevention of postoperative venous thromboembolism. A meta-analysis. 154:67-72. 1994
Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. 153:2777-2780. 1993
Evaluation of a portable prothrombin time monitor for home use by patients who require long-term oral anticoagulant therapy. 153:1441-1447. 1993
Lovastatin 5-year safety and efficacy study. Lovastatin Study Groups I through IV. 153:1079-1087. 1993
Coffee and Coronary Heart Disease. 153:902-902. 1993
The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy. A randomized crossover study. 153:841-844. 1993
Optimal dose for starting and maintaining low-dose aspirin. 153:700-702. 1993
Coffee and coronary heart disease. 152:1767-1772. 1992
Effectiveness and efficiency of selective vs universal screening for chlamydial infection in sexually active young women. 152:1837-1844. 1992
Optimal therapeutic level of heparin therapy in patients with venous thrombosis. 152:1589-1595. 1992
A critical appraisal of ticlopidine, a new antiplatelet agent. Effectiveness and clinical indications for prophylaxis of atherosclerotic events. 152:1376-1380. 1992
Substandard monitoring of warfarin in North America. Time for change. 152:257-258. 1992
Thrush Can Be Prevented in Patients With Acquired Immunodeficiency Syndrome and the Acquired Immunodeficiency Syndrome—Related Complex. 151:2458-2458. 1991
Clinical Use of the Heparin Nomogram-Reply. 151:2321-2321. 1991
Influence of low-intensity warfarin treatment on patients' perceptions of quality of life. 151:1921-1922. 1991
A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. 151:1721-1731. 1991
A standard heparin nomogram for the management of heparin therapy. 151:333-337. 1991
How common is postpartum thyroiditis? A methodologic overview of the literature. 150:1397-1400. 1990
Methotrexate in rheumatoid arthritis. Impact on quality of life assessed by traditional standard-item and individualized patient preference health status questionnaires. 150:59-62. 1990
A new noninvasive management strategy for patients with suspected pulmonary embolism. 149:2549-2555. 1989
The Ontario cohort study of running-related injuries. 149:2561-2564. 1989
Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography. 149:2255-2257. 1989
Heparin therapy during pregnancy. Risks to the fetus and mother. 149:2233-2236. 1989
Intermittent compression units for the postphlebitic syndrome. A pilot study. 149:1651-1652. 1989
A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. 149:771-774. 1989
Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. 149:679-681. 1989
Acute response to bronchodilator. An imperfect guide for bronchodilator therapy in chronic airflow limitation. 148:1949-1952. 1988
Pulmonary embolism in outpatients with pleuritic chest pain. 148:838-844. 1988
Clinical utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. 148:519-520. 1988
Computer-aided quality assurance. A critical appraisal. 147:1297-1301. 1987
Is the dose of warfarin prescribed by American physicians unnecessarily high?. 147:769-771. 1987
Heroin vs morphine for cancer pain?. 146:353-356. 1986
Chronic cough and the use of captopril: unmasking asthma. 146:202-203. 1986
Massive Skeletal Muscle Invasion by Lymphoma. 145:1818-1818. 1985
Recurrent leg symptoms following deep vein thrombosis. A diagnostic challenge. 145:1867-1869. 1985
The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. 145:1835-1839. 1985
The optimal antithrombotic dose of aspirin. 145:1582-1583. 1985
A multicenter comparative trial of tobramycin and ticarcillin vs moxalactam and ticarcillin in febrile neutropenic patients. 145:1083-1088. 1985
Effect of diuretics on cardiopulmonary performance in severe chronic airflow obstruction. A controlled clinical trial. 144:2154-2157. 1984
Heparin Side Effects—Reply. 144:1693-1693. 1984
Long-term anticoagulant therapy in patients with venous thrombosis. 143:2061-2063. 1983
Problems in the handling of clinical and research evidence by medical practitioners. 143:1971-1975. 1983
Selection and results of antiplatelet therapy in the prevention of stroke and myocardial infarction. 141:311-315. 1981
Inappropriate antidiuretic hormone complicating histiocytic lymphoma. 139:307-308. 1979
Cerebrospinal fluid prolactin: a reevaluation. 139:208-211. 1979
A rapid method for the diagnosis of acute uric acid nephropathy. 138:612-615. 1978
The red blood cell as a model for the study of uremic toxins. 126:827-830. 1970
Decision Aids for Prostate Cancer Screening Choice 2019
Nonleg Venous Thrombosis in Critically Ill Adults 2014
Exclusive Staphylococcus aureus Throat Carriage 2009
Helping Patients With Type 2 Diabetes Mellitus Make Treatment Decisions 2007
Pharmacist Medication Assessments in a Surgical Preadmission Clinic 2007
The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With Enoxaparin<subtitle>A Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee Arthroplasty</subtitle> 1998

JAMA Internal Medicine Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)